15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering eHealth Inc, 0 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets range widely, $2.00 to $5.00 (about 2.5x), a sign of real disagreement on valuation. The average target of $3.33 sits 145% above the current $1.36. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.34 next quarter toward $-0.65 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to eHealth Inc.
As of Jul, 0 of 3 firms rate EHTH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EHTH EPS & revenue forecast
EPS · NEXT QUARTER
$-1.34
Range $-1.49 – $-1.12 · 4 analysts · -8% YoY
Next period, 4 analysts expect eHealth Inc to earn $-1.34 a share (range $-1.49 – $-1.12), versus $-1.46 a year earlier. Full-year consensus is $-1.07, growing to $-0.65 the year after.
REVENUE · NEXT QUARTER
$33.7M
Range $30.2M – $36.9M · 4 analysts · -37% YoY
Revenue is expected to reach $33.7M (range $30.2M – $36.9M), -37.4% year-over-year. Full-year consensus is $429.2M, rising to $447.3M next year.
Top analysts covering eHealth Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EHTH.
#1
George Sutton
Craig-Hallum · Rank #114
Hold
$2.00+47.1% to target
Overall win rate
36%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Hold
$3.00+120.6% to target
Overall win rate
44%
+ Follow
#3
JY
Jonathan Yong
UBS
Hold
$2.00+47.1% to target
Coverage
—
+ Follow
#4
AK
Adam Klauber
William Blair
Hold
No targeton EHTH
Coverage
—
+ Follow
#5
FM
Frank Morgan
RBC Capital
Hold
$11.00+708.8% to target
Coverage
—
+ Follow
EHTH stock forecast FAQ
What is EHTH's average 12-month price target?+
The 3 analysts with a live target average $3.33 for eHealth Inc over the next 12 months, ranging from a $5.00 high to a $2.00 low.
Is EHTH stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EHTH?+
The Street-high target is $5.00 (UBS), and the Street-low is $2.00 (Craig-Hallum). The average of all 3 active targets is $3.33.
How many Wall Street analysts cover EHTH?+
3 analysts have an active rating on eHealth Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering EHTH?+
Among analysts who currently cover EHTH, George Sutton of Craig-Hallum has the strongest overall Quantellect track record (Rank #114). Their current call is Hold with a $2.00 target.
What is eHealth Inc's projected EPS for next quarter?+
The consensus estimate is $-1.34 per share (range $-1.49 – $-1.12) across 4 analysts. Full-year EPS is projected at $-1.07, rising to $-0.65 the following year.
How much revenue is eHealth Inc expected to report next quarter?+
Consensus revenue is $33.7M (range $30.2M – $36.9M). Full-year revenue is projected at $429.2M, growing to $447.3M next year.
Have analysts been upgrading or downgrading EHTH lately?+
As of Jul, 0 of 3 firms rate EHTH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EHTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
